{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-064413","form_type":"8-K","ticker":"ATYR","cik":"0001339970","company_name":"aTYR PHARMA INC","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.020084+00:00","generated_at":"2026-05-22T11:16:13.303651+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"aTyr Pharma shareholders approve 5M share increase to equity plan; elect two directors","bullets":["Stockholders approved amendment to 2015 Stock Plan, increasing share reserve by 5,000,000 to 15,719,300 shares.","Incentive stock option term extended to February 26, 2035.","Class I directors Paul Schimmel and Sara L. Zaknoen elected with 56.6M and 49.0M votes for, respectively.","Ratification of Ernst & Young as auditor for FY2025 approved (68.9M for, 175K against).","Advisory vote on named executive officer compensation approved (55.2M for, 1.35M against)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-064413","json":"https://secwatch.observer/filing/0000950170-25-064413.json","markdown":"https://secwatch.observer/filing/0000950170-25-064413.md","text":"https://secwatch.observer/filing/0000950170-25-064413.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339970/000095017025064413/0000950170-25-064413-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339970/000095017025064413/atyr-20240522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T11:16:13.303651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}